15,733 research outputs found
Building health research systems to achieve better health
Health research systems can link knowledge generation with practical concerns to improve health
and health equity. Interest in health research, and in how health research systems should best be
organised, is moving up the agenda of bodies such as the World Health Organisation. Pioneering
health research systems, for example those in Canada and the UK, show that progress is possible.
However, radical steps are required to achieve this. Such steps should be based on evidence not
anecdotes.
Health Research Policy and Systems (HARPS) provides a vehicle for the publication of research, and
informed opinion, on a range of topics related to the organisation of health research systems and
the enormous benefits that can be achieved. Following the Mexico ministerial summit on health
research, WHO has been identifying ways in which it could itself improve the use of research
evidence. The results from this activity are soon to be published as a series of articles in HARPS.
This editorial provides an account of some of these recent key developments in health research
systems but places them in the context of a distinguished tradition of debate about the role of
science in society. It also identifies some of the main issues on which 'research on health research'
has already been conducted and published, in some cases in HARPS. Finding and retaining adequate
financial and human resources to conduct health research is a major problem, especially in low and
middle income countries where the need is often greatest. Research ethics and agenda-setting that
responds to the demands of the public are issues of growing concern. Innovative and collaborative
ways are being found to organise the conduct and utilisation of research so as to inform policy, and
improve health and health equity. This is crucial, not least to achieve the health-related Millennium
Development Goals. But much more progress is needed. The editorial ends by listing a wide range
of topics related to the above priorities on which we hope to feature further articles in HARPS and
thus contribute to an informed debate on how best to achieve such progress
Evidence for the saturation of the Froissart bound
It is well known that fits to high energy data cannot discriminate between
asymptotic ln(s) and ln^2(s) behavior of total cross section. We show that this
is no longer the case when we impose the condition that the amplitudes also
describe, on average, low energy data dominated by resonances. We demonstrate
this by fitting real analytic amplitudes to high energy measurements of the
gamma p total cross section, for sqrt(s) > 4 GeV. We subsequently require that
the asymptotic fit smoothly join the sqrt(s) = 2.01 GeV cross section described
by Dameshek and Gilman as a sum of Breit-Wigner resonances. The results
strongly favor the high energy ln^2(s) fit of the form sigma_{gamma p} = c_0 +
c_1 ln(nu/m) + c_2 ln^2(nu/m) + beta_{P'}/sqrt(nu/m), basically excluding a
ln(s) fit of the form sigma_{\gamma p} = c_0 + c_1 ln(nu/m) +
beta_P'/sqrt(\nu/m), where nu is the laboratory photon energy. This evidence
for saturation of the Froissart bound for gamma p interactions is confirmed by
applying the same analysis to pi p data using vector meson dominance.Comment: 7 pages, Latex2e, 4 postscript figures, uses epsf.st
Adaptive Ising Model and Bacterial Chemotactic Receptor Network
We present a so-called adaptive Ising model (AIM) to provide a unifying
explanation for sensitivity and perfect adaptation in bacterial chemotactic
signalling, based on coupling among receptor dimers. In an AIM, an external
field, representing ligand binding, is randomly applied to a fraction of spins,
representing the states of the receptor dimers, and there is a delayed negative
feedback from the spin value on the local field. This model is solved in an
adiabatic approach. If the feedback is slow and weak enough, as indeed in
chemotactic signalling, the system evolves through quasi-equilibrium states and
the ``magnetization'', representing the signal, always attenuates towards zero
and is always sensitive to a subsequent stimulus.Comment: revtex, final version to appear in Europhysics Letter
R\'enyi entanglement entropy of critical SU() spin chains
We present a study of the scaling behavior of the R\'{e}nyi entanglement
entropy (REE) in SU() spin chain Hamiltonians, in which all the spins
transform under the fundamental representation. These SU() spin chains are
known to be quantum critical and described by a well known Wess-Zumino-Witten
(WZW) non-linear sigma model in the continuum limit. Numerical results from our
lattice Hamiltonian are obtained using stochastic series expansion (SSE)
quantum Monte Carlo for both closed and open boundary conditions. As expected
for this 1D critical system, the REE shows a logarithmic dependence on the
subsystem size with a prefector given by the central charge of the SU() WZW
model. We study in detail the sub-leading oscillatory terms in the REE under
both periodic and open boundaries. Each oscillatory term is associated with a
WZW field and decays as a power law with an exponent proportional to the
scaling dimension of the corresponding field. We find that the use of periodic
boundaries (where oscillations are less prominent) allows for a better estimate
of the central charge, while using open boundaries allows for a better estimate
of the scaling dimensions. For completeness we also present numerical data on
the thermal R\'{e}nyi entropy which equally allows for extraction of the
central charge.Comment: 8 pages, 13 figure
The Circadian Clock Gene Period1 Connects the Molecular Clock to Neural Activity in the Suprachiasmatic Nucleus.
The neural activity patterns of suprachiasmatic nucleus (SCN) neurons are dynamically regulated throughout the circadian cycle with highest levels of spontaneous action potentials during the day. These rhythms in electrical activity are critical for the function of the circadian timing system and yet the mechanisms by which the molecular clockwork drives changes in the membrane are not well understood. In this study, we sought to examine how the clock gene Period1 (Per1) regulates the electrical activity in the mouse SCN by transiently and selectively decreasing levels of PER1 through use of an antisense oligodeoxynucleotide. We found that this treatment effectively reduced SCN neural activity. Direct current injection to restore the normal membrane potential partially, but not completely, returned firing rate to normal levels. The antisense treatment also reduced baseline [Ca(2+)]i levels as measured by Fura2 imaging technique. Whole cell patch clamp recording techniques were used to examine which specific potassium currents were altered by the treatment. These recordings revealed that the large conductance [Ca(2+)]i-activated potassium currents were reduced in antisense-treated neurons and that blocking this current mimicked the effects of the anti-sense on SCN firing rate. These results indicate that the circadian clock gene Per1 alters firing rate in SCN neurons and raise the possibility that the large conductance [Ca(2+)]i-activated channel is one of the targets
Recommended from our members
The utilisation of health research in policy-making: Concepts, examples, and methods of assessment
Chapter 1: Introduction and Background
• The importance of utilising health research in policy-making, and therefore the need to understand the mechanisms involved, is increasingly recognised. Recent reports calling for more resources to improve health in developing countries, and global pressures for accountability, draw greater attention to research-informed policy-making.
• For at least twenty years there has been recognition of the multiple meanings or models of research utilisation in policy-making. It has similarly been long recognised that a range of factors is involved in the interactions between health research and policy-makers.
• The emerging focus on Health Research Systems (HRS) has identified additional mechanisms through which greater utilisation of research could be achieved. Assessment of the role of health research in policy-making is best undertaken as part of a wider study that also includes the utilisation of health research by industry, medical practitioners, and the public.
Chapter 2: The Nature of Policy-Making, Types of Research and Utilisation Models
• Policy-making broadly interpreted includes national health policies made by government ministers and officials, policies made by local health service managers, and clinical guidelines from professional bodies. In this report, however, the main focus is on public policy-making rather than that conducted by professional bodies. The utilisation of health research in policy-making should eventually lead to desired outcomes, including health gains. Research can make a contribution in at least three phases of the policy-making process: agenda setting; policy formulation; and implementation. Descriptions of these processes, however, can over-estimate the degree of rationality in policy-making. Therefore, the analysis is informed by a review of the full range of policy-making models. These include rational and incrementalist models.
• Various categories of research are likely to be used differently in health policy-making. Applied research might be more readily useable by a policy system than basic research, but health policy-makers tend to relate more willingly to natural sciences than social sciences. When research is based on the priorities of potential users, and/or is research of proven quality, this increases the possibility that it will be translated into policies. There also appears to be a greater chance of research being used in clinical policies about delivering care to patients, than in national policies on the structures of the health service.
• Models of research utilisation in policy-making start with a link to rational or instrumental views of policy-making, and include descriptions of how commissioned research can help to find solutions to problems. Other models relate to an incrementalist view in which policy-making involves a series of small steps over a long period; research findings might gradually cause a shift in perceptions about an issue in a process of ‘enlightenment’. Interactive models of research utilisation stress the way in which policy-makers and researchers might develop links over a long period. Research can also be used symbolically to support decisions already taken.
Chapter 3: Examples from Previous Studies
• A study of health policy-making in two southern African countries illustrates how policy-making processes can be analysed. It addresses agenda setting, policy formulation and implementation. The methods used included documentary analysis and key informant interviews.
• Many previous studies of research utilisation can provide lessons for future assessments. Two broad approaches can be identified. Some studies start with pieces, or programmes, of research and examine their impact. Others consider policy on a particular topic and assess the role of research in the policy-making. There are advantages and drawbacks in each approach, and overlaps between them.
• To facilitate comparison, studies of research utilisation are best organised around a conceptual framework. Despite that, the influence of contextual factors in different settings makes it difficult to generalise.
• The two methods used most frequently, and usually together, come from the qualitative tradition: documentary analysis and in-depth interviews. Questionnaires, bibliometric analysis, insider knowledge and historical approaches have all been applied. A few recent studies have attempted to score or scale the level of utilisation.
• The examples suggest there is a greater level of utilisation and final outcomes in terms of health, health equity, and social and economic gain than is often assumed, whilst still showing much underutilisation. There is considerable variation in the degree of utilisation, both within and between studies.
Chapter 4: Key Issues in the Analysis of Research Utilisation in Policy-Making
• Increasing attention is focusing on the concept of interfaces between researchers and the users of research. This incorporates the idea that there are likely to be different values and interests between the two communities.
• In relation to utilisation, the prioritisation debate revolves around two key aspects: whether priorities are being set that will produce research that policy-makers and others will want to use, and whether priorities are being set that will engage the interests and commitment of the research community.
• Interactions across the interface between policy-makers and researchers are important in transferring research to policy-makers. This fits especially well with the interactive model of utilisation. Actions by individual researchers can be useful in generating interaction, but it is desirable to consider the role of the HRS in encouraging or facilitating interactions, networks and mechanisms at a system-wide level. The HRS could provide funding and organisational support for various items including: long-term research centres; research brokerage/translator mechanisms; the creation of official committees of policy-makers and researchers; and mechanisms for review and synthesis of research findings.
• There is increased recognition of the significance of policy-makers in their role as the receptors of research. In relation to the perspective of policy-makers there is a spectrum of key questions. These range from whether relevant research is available and effectively being brought to their attention, to whether they are able to absorb it and willing to use it. The HRS has a responsibility, especially in the early parts of the spectrum, but the wider health system also has a responsibility to create appropriate institutional mechanisms and ensure there are staff willing and able to incorporate relevant research.
• More attention should be given to the role of incentives, both for researchers to produce utilisable research, and for policy-makers, at the system or individual level, to use it. The assessment of utilisation becomes a key issue if rewards are to focus on relevance as well as research excellence.
• An appropriate model for assessing research utilisation in policy-making combines analysis of two issues: the role of receptors and the importance of actions at the interfaces. An emphasis on the role of the receptor is necessary because ultimately it is up to the policy-maker to make the decisions. Any assessment of the success of the HRS in relation to utilisation must accept that the wider political context is beyond the control of the HRS, but consider the activities of the HRS, within its given context, to enhance the utilisation of research by increasing the permeability of the interfaces.
Chapter 5: Assessment of Research Utilisation in Health Policy-Making
• The reasons for assessing the utilisation of research in policy-making include: advocacy, accountability, and increased understanding. For the World Health Organization there could be a role in conducting such assessments with the aim of providing evidence of the effective use of research resources. This could support advocacy for greater resources to be made available for health research. It is important that the purposes of any assessment are taken into account in planning the methods to be used.
• Previous studies demonstrated the difficulties of making generalisations about specific factors associated with high levels of utilisation. To address this in any cross-national WHO initiative involving a series of studies in a range of countries, it would be desirable to structure all the studies around a conceptual framework (such as the interfaces and receptor framework considered here) and base the studies in each country on common themes. These could include policies for the adoption of multi-drug therapy for treating leprosy, and for the equitable access to health services.
• Analysis of documents and semi-structured interviews would be appropriate methods in each study assessing the role of research in policy-making on a specific policy theme. Questionnaires could also have a role. These approaches would provide triangulation of methods and data-sources and should also provide material to help identify the relative importance, in relation to the level of utilisation recorded, of the HRS mechanisms described in the previous analysis. The types and sources of research used, and reasons for their use, should also be recorded and attempts made to correlate them with the previous priority setting approaches. It is expected that each study will produce its own narrative or story of what caused utilisation in the particular context, but the data gathered could also be applied to descriptive scales of the level research utilisation. The four scales could cover the consistency of policy with research findings, and the degree of influence of research on agenda setting, policy formulation, and implementation.
• The findings from the assessments in each participating country should be collated. For each policy theme or topic the analysis would compare two sets of data: the scales for level of research utilisation in each country, and the contextualised lists of the HRS activities and other mechanisms and networks thought to be important. Although the account here has focused on research impact on policy-making, the evaluations would be stronger as part of a wider analysis covering research utilisation and interactions with practitioners, industry and the public.
• Given appropriate and targeted topic and country selection, this approach is likely to meet the purpose of using structured methods to provide examples of effective research utilisation. The approach should contribute towards enhanced understanding of the issues and could provide the basis of an assessment tool which, if used widely in countries, could lead to greater utilisation of health research.Research Policy and Co-operation (RPC) Department of the World Health Organization, Geneva; UK Department of Health’s Policy Research Programme; Alliance for Health Policy and Systems Research from the governments of Norway and Sweden; World Bank and International Development Research Council of Canad
Photography: A Survey of New Reference Sources
What a difference a few years make! In the fall 1982 issue of Reference Services Review I described forty reference monographs and serial publications on photography. That article concluded with these words, "a careful reader will be aware that not one single encyclopedia or solely biographical source was included... this reviewer could find none in print... A biographical source proved equally elusive" (p.28)
- …